BUY Aurobindo Pharma — Amit Seth
byAmit SethHorizon: NA (inferred Intraday)24 Sept 2026, 11:31 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Multiple growth triggers ahead for Aurobindo Pharma as outlook stays strong
NewsGoogle News·22 Sept · yesterday
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·21 Sept · 3d ago
Aurobindo Pharma stock edges higher as US tariff risks and FDA approvals shape outlook
NewsGoogle News·19 Sept · 4d ago
Aurobindo Pharma Share Price rises: stock analysis note
NewsGoogle News·17 Sept · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aurobindo Pharma
- BUY — Nuvama Wealth6 Nov 2026 · ~1 year · target ₹2,195 · Active
- BUY — Goldman Sachs6 Nov 2026 · ~1 year · target ₹2,000 · Active
- SELL — Citigroup5 Nov 2026 · ~1 year · target ₹1,270 · Active
- BUY — Raja Venkatraman5 Nov 2026 · ~3 months · target ₹1,875 · Active
- BUY — Prakash Gaba4 Nov 2026 · Same day · target ₹1,725 · Expired
More from Amit Seth
- BUY Bharti Airtel13 Nov 2026 · ~2 weeks · target ₹2,175 · Active
- BUY Bharat Heavy Electricals13 Nov 2026 · Next day · target ₹445 · Active
- BUY Craftsman Automation13 Nov 2026 · ~2 weeks · target ₹11,600 · Active
- BUY Bharti Airtel13 Nov 2026 · ~2 weeks · target ₹2,160 · Active
- BUY Radico Khaitan12 Nov 2026 · ~2 weeks · target ₹4,750 · Active

